These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25688069)

  • 21. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
    Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
    Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for natural horizontal transfer of tetO gene between Campylobacter jejuni strains in chickens.
    Avrain L; Vernozy-Rozand C; Kempf I
    J Appl Microbiol; 2004; 97(1):134-40. PubMed ID: 15186450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Campylobacter jejuni isolates implicated in Guillain-Barré syndrome and strains that cause enteritis by a DNA microarray.
    Leonard EE; Tompkins LS; Falkow S; Nachamkin I
    Infect Immun; 2004 Feb; 72(2):1199-203. PubMed ID: 14742576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial infections in Guillain-Barré and Fisher syndromes.
    Yuki N; Koga M
    Curr Opin Neurol; 2006 Oct; 19(5):451-7. PubMed ID: 16969154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of antimicrobial sensitivities of Campylobacter jejuni isolated from commercial turkey farms in Germany.
    El-Adawy H; Hotzel H; Düpre S; Tomaso H; Neubauer H; Hafez HM
    Avian Dis; 2012 Dec; 56(4):685-92. PubMed ID: 23397839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Campylobacter genes responsible for the development and determinant of clinical features of Guillain-Barré syndrome].
    Yuki N
    Nihon Rinsho; 2008 Jun; 66(6):1205-10. PubMed ID: 18540372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland.
    Wardak S; Szych J; Zasada AA; Gierczynski R
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1123-5. PubMed ID: 17210776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbohydrate mimicry: a new paradigm of autoimmune diseases.
    Yuki N
    Curr Opin Immunol; 2005 Dec; 17(6):577-82. PubMed ID: 16229995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-mhz (1)h and (13)c NMR analysis.
    Gilbert M; Brisson JR; Karwaski MF; Michniewicz J; Cunningham AM; Wu Y; Young NM; Wakarchuk WW
    J Biol Chem; 2000 Feb; 275(6):3896-906. PubMed ID: 10660542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic identification of genetic loci required for polymyxin resistance in Campylobacter jejuni using an efficient in vivo transposon mutagenesis system.
    Lin J; Wang Y; Hoang KV
    Foodborne Pathog Dis; 2009 Mar; 6(2):173-185. PubMed ID: 19105633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
    Ge B; McDermott PF; White DG; Meng J
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3347-54. PubMed ID: 16048946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Campylobacter DNA is present in circulating myelomonocytic cells of healthy persons and in persons with Guillain-Barré syndrome.
    Van Rhijn I; Bleumink-Pluym NM; Van Putten JP; Van den Berg LH
    J Infect Dis; 2002 Jan; 185(2):262-5. PubMed ID: 11807702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance profiles and mechanisms of resistance in Campylobacter jejuni isolates from pets.
    Acke E; McGill K; Quinn T; Jones BR; Fanning S; Whyte P
    Foodborne Pathog Dis; 2009; 6(6):705-10. PubMed ID: 19580444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli.
    Hänninen ML; Hannula M
    J Antimicrob Chemother; 2007 Dec; 60(6):1251-7. PubMed ID: 17911389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of Cj1136, Cj1138 and Cj1139 genes among Campylobacter jejuni strains].
    Li X; Li ZZ; Bai XL; Liu H; Zhao ZC; Liu WW; Gao AM; Xing CC; Li CY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Aug; 30(8):829-31. PubMed ID: 20193208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic evidence for interspecies acquisition of chromosomal DNA from Campylobacter jejuni by Campylobacter coli strains of a turkey-associated clonal group (cluster II).
    Chan K; Elhanafi D; Kathariou S
    Foodborne Pathog Dis; 2008 Aug; 5(4):387-98. PubMed ID: 18673073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of orally administered tetracycline on the intestinal community structure of chickens and on tet determinant carriage by commensal bacteria and Campylobacter jejuni.
    Fairchild AS; Smith JL; Idris U; Lu J; Sanchez S; Purvis LB; Hofacre C; Lee MD
    Appl Environ Microbiol; 2005 Oct; 71(10):5865-72. PubMed ID: 16204498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.
    Poly F; Read TD; Chen YH; Monteiro MA; Serichantalergs O; Pootong P; Bodhidatta L; Mason CJ; Rockabrand D; Baqar S; Porter CK; Tribble D; Darsley M; Guerry P
    Infect Immun; 2008 Dec; 76(12):5655-67. PubMed ID: 18809665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.